They started this in March and ran it for 4 months. So a few days ago I emailed the Turkish doctor about the results. This morning he sent me the results. This is the preliminary, before publication in the Lancet results, you heard it first!!: The original study description: https://clinicaltrials.gov/ct2/show/NCT04377789 Results before publication: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3682517 "Results: A total of 113 persons included. No significant difference detected between groups in terms of other features.Mean age of QCB group was 39.0 ± 8.8 years and control group was 32.9 ± 8.7.Average follow-up period for the QCB group was 113 days, and for the control group, 118, during follow-up period, 1 healthcare worker in QCB group and 9 out of 42 in control group had COVID-19.One of cases was asymptomatic, while others were not.Transmission risk hazard ratio whose did not receive QCB was 12.04 (95% Confidence interval= 1.26-115.06, P = 0.031).No significant effect of gender, smoking, antihypertensive medication exposure and having chronic disease on rate of transmission. Conclusion: This study revealed that QCB was protective for healthcare workers.Trial registration NCT04377789"
I know the Canadian team at the IRCM was doing a trial in China early on, never heard anything on that one? https://www.mcgilltribune.com/sci-tech/montreal-researchers-propose-a-treatment-for-covid-19-170320/
If they have a contact info, email or call them. As my example shows, they don't mind to give out info, at least somebody is interested in their research. I have a feeling this study will be buried, not much extra money to be made.